Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression

Zou, XH; Fan, WZ; Xue, M; Li, JP

Li, JP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.

CANCER MANAGEMENT AND RESEARCH, 2021; 13 (): 4013

Abstract

Purpose: Outcomes after the treatment for unresectable or advanced-stage hepatocellular carcinoma (HCC) are unsatisfied. We evaluated the therapeutic ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索